Del-1 protein level in serum was calculated by ELISA from healthy controls (n = 81), breast cancer patients (n = 269), breast cancer patients after surgical resection (n = 50), patients with benign breast tumors (n = 64), and patients with noncancerous diseases (n = 98) in two cohorts. Here, EDIL3 is linked to breast benign neoplasm.